Ra Medical Systems Statistics Share Statistics Ra Medical Systems has 6.46M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 6.46M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 3.94M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 121.58K, so 0% of the outstanding
shares have been sold short.
Short Interest 121.58K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.09 and the forward
PE ratio is null.
Ra Medical Systems's PEG ratio is
0.
PE Ratio -0.09 Forward PE n/a PS Ratio 4.47 Forward PS n/a PB Ratio 0.16 P/FCF Ratio -0.2 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ra Medical Systems.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.58,
with a Debt / Equity ratio of 0.15.
Current Ratio 1.58 Quick Ratio 1.56 Debt / Equity 0.15 Debt / EBITDA -0.16 Debt / FCF -0.19 Interest Coverage 123.55
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $30K Profits Per Employee $-1.56M Employee Count 14 Asset Turnover 0.02 Inventory Turnover 1.27
Taxes Income Tax 3.14M Effective Tax Rate -23.26%
Stock Price Statistics The stock price has increased by 2.61% in the
last 52 weeks. The beta is 0, so Ra Medical Systems's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change 2.61% 50-Day Moving Average 0.62 200-Day Moving Average 1.97 Relative Strength Index (RSI) 49.19 Average Volume (20 Days) 290,931
Income Statement In the last 12 months, Ra Medical Systems had revenue of 420K
and earned -21.8M
in profits. Earnings per share was -6.68.
Revenue 420K Gross Profit 378K Operating Income -11.24M Net Income -21.8M EBITDA -11.24M EBIT n/a Earnings Per Share (EPS) -6.68
Full Income Statement Balance Sheet The company has 2.87M in cash and 1.79M in
debt, giving a net cash position of 1.08M.
Cash & Cash Equivalents 2.87M Total Debt 1.79M Net Cash 1.08M Retained Earnings -292.35M Total Assets 24.8M Working Capital -3.23M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.27M
and capital expenditures -67K, giving a free cash flow of -9.34M.
Operating Cash Flow -9.27M Capital Expenditures -67K Free Cash Flow -9.34M FCF Per Share -2.86
Full Cash Flow Statement Margins Gross margin is 90%, with operating and profit margins of -2676.9% and -5190.71%.
Gross Margin 90% Operating Margin -2676.9% Pretax Margin -3214.76% Profit Margin -5190.71% EBITDA Margin -2676.9% EBIT Margin -2676.9% FCF Margin -2223.33%
Dividends & Yields RMED does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for RMED.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 3, 2022. It was a
backward
split with a ratio of 1:50.
Last Split Date Oct 3, 2022 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -11.14 Piotroski F-Score 5
